Search: onr:"swepub:oai:lup.lub.lu.se:a59be422-5676-41ae-adf6-82b459adc212" >
Early response to i...
Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
-
Calverley, Peter M (author)
-
Postma, Dirkje S (author)
-
Anzueto, Antonio R (author)
-
show more...
-
Make, Barry J (author)
-
- Eriksson, Göran (author)
- Lund University,Lunds universitet,Lungmedicin, allergologi och palliativ medicin,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Respiratory Medicine, Allergology, and Palliative Medicine,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital
-
Peterson, Stefan (author)
-
Jenkins, Christine R (author)
-
show less...
-
(creator_code:org_t)
- 2016
- 2016
- English.
-
In: The International Journal of Chronic Obstructive Pulmonary Disease. - 1178-2005. ; 11, s. 381-390
- Related links:
-
http://www.ncbi.nlm.... (free)
-
show more...
-
http://dx.doi.org/10... (free)
-
https://lup.lub.lu.s...
-
https://doi.org/10.2...
-
show less...
Abstract
Subject headings
Close
- Early treatment response markers, for example, improvement in forced expiratory volume in 1 second (FEV1) and St George's Respiratory Questionnaire (SGRQ) total score, may help clinicians to better manage patients with chronic obstructive pulmonary disease (COPD). We investigated the prevalence of clinically important improvements in FEV1 and SGRQ scores after 2-month budesonide/formoterol or formoterol treatment and whether such improvements predict subsequent improvements and exacerbation rates.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
To the university's database